Data Bridge Market Research analyzes that the Global Fluorescent in Situ Hybridization (FISH) Market is expected to grow at a CAGR of 8.2% in the forecast period of 2023 to 2030 and is expected to reach USD 1,830.55 million by 2030. The consumables segment is projected to propel the market growth as they are widely used in the FISH technology for the diagnosis of genetic disorders in various regions and more due to the availability of more advanced technologies. Especially, these consumables have a broad range of applications for research and clinical purposes among others.
Data Bridge Market Research analyzes that the global Fluorescent in Situ Hybridization (FISH) market is expected to reach a value of USD 1,830.55 million by 2030, at a CAGR of 8.2% during the forecast period. The product type segment accounts for the largest segment in the market due to the rising number of breast cancer and genetic disorders among patients. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
Request a Sample PDF: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-fluorescent-in-situ-hybridization-fish-market&Shri
Growing Burden of Genetic Disorders as well as Cancer
Genetic abnormalities are uncommon as a whole but are very frequent as individual ailments. Gene changes are the cause of all cancer. Just 5% to 10% of cancers are genetically predisposed. Nevertheless, when the same cancer types run in families, heredity may occasionally seem to be the cause of cancer. Hematologic and solid cancers are both heterogeneous diseases with various genetic abnormalities. An increasing number of genomic abnormalities, such as gain, loss, or rearrangement of chromosomal fragments and gene mutations, have been found to be driving factors in the pathogenesis of various malignancies as a result of the extensive investigations into the relationship between genomic instability and disease pathogenesis conducted over the last two decades. The clinical diagnosis of different chromosomal abnormalities, including deletions, duplications, and translocations, depends on FISH and other in situ hybridization techniques.
Market Definition
A molecular cytogenetic technique called Fluorescence in Situ Hybridization (FISH) enables the localization of a particular DNA sequence or an entire chromosome in a cell. It is used to diagnose genetic disorders, map genes, identify chromosomal anomalies, and may also be used to compare how the genes on different chromosomes in related species are organized. While performing FISH, the double helix structure is unwound and all probes connected to fluorescent molecules are bound to a particular sequence of sample DNA that can be seen under a fluorescence microscope.
FISH is frequently used for diagnostic purposes in oncology, preventative and reproductive health, and genomic and cell biology research. It is the industry-recognized method for finding infectious illnesses and chromosomal abnormalities. However, strict regulations and standards for the approval of FISH products and probes are expected to restrain the market growth.
Opportunity
Genetic testing aids patients in making important decisions in the prevention, treatment, or early detection of hereditary disorders. Low awareness of the importance of genetic testing contributes to the increase in the incidence of hereditary disorders.
A genetic disorder is a health condition that is inherited by a person, usually caused by mutations in the DNA or changes in the number or overall structure of chromosomes. Several types of commonly known diseases have been determined to be related to hereditary gene mutations.
Henceforth, the rising awareness about the early detection of genetic disorders using the FISH technique helps in the diagnosis of genetic diseases, gene mapping, and identification of novel oncogenes or genetic aberrations contributing to various types of cancers and genetic disorders, which provides the opportunity for market growth.
Recent Developments
Browse Complete Report Details- https://www.databridgemarketresearch.com/reports/global-fluorescent-in-situ-hybridization-fish-market?Shri
Some of the major market players operating in the global Fluorescent in Situ Hybridization (FISH) market are Thermo Fisher Scientific Inc., Bio-Techne, Abbott, Agilent Technologies, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Abnova Corporation, BioDot, Biocare Medical, LLC, Abcam plc., Sysmex Asia Pacific Pte Ltd (a subsidiary of Sysmex Corporation), BIOZOL Diagnostics Vertrieb GmbH, Zytomed Systems GmbH, Genemed Biotechnologies, Inc., Bio SB, BioGenex, Excilone, MetaSystems, Kaneka Eurogentec S.A., BioCat GmbH, and Leica Biosystems Nussloch GmbH among others.
Fluorescent in Situ Hybridization (FISH) Market Scope
BY PRODUCT TYPE
Based on product type, the market is segmented into consumables, instrument, and software.
BY TECHNOLOGY
Based on technology, the market is segmented into DNA fluorescent in situ hybridization, RNA fluorescent in situ hybridization, PNA fluorescent in situ hybridization, and others.
BY APPLICATION
Based on application, the market is segmented into cancer research, genetic research, infectious disease, personalized medicine, and other.
BY USAGE
Based on usage, the market is segmented into clinical, research, and companion diagnostic.
BY END USER
Based on end user, the market is segmented into hospitals & clinics, diagnostic laboratories, pharmaceuticals & biotechnology companies, contract research organizations, academic & research institutes, and others.
BY DISTRIBUTION CHANNEL
Drivers
Genetic abnormalities are uncommon as a whole but are very frequent as individual ailments. Gene changes are the cause of all cancer. Just 5% to 10% of cancers are genetically predisposed. Nevertheless, when the same cancer types run in families, heredity may occasionally seem to be the cause of cancer. Hematologic and solid cancers are both heterogeneous diseases with various genetic abnormalities. An increasing number of genomic abnormalities such as gain, loss, or rearrangement of chromosomal fragments and gene mutations, are driving factors in the pathogenesis of various malignancies as a result of the extensive investigations into the relationship between genomic instability and disease pathogenesis conducted over the last two decades. The clinical diagnosis of different chromosomal abnormalities, including deletions, duplications, and translocations, depends on FISH and other in situ hybridization techniques, which drives market growth.
Key Advantages of the Report:
What to Anticipate from the Report – A 7-Point Guide:
Top DBMR Healthcare Reports:
Global Throat Cancer Diagnostics Market https://www.databridgemarketresearch.com/reports/global-throat-cancer-diagnostics-market
Europe Throat Cancer Diagnostics Market https://www.databridgemarketresearch.com/reports/europe-throat-cancer-diagnostics-market
Asia-Pacific Throat Cancer Diagnostics Market https://www.databridgemarketresearch.com/reports/asia-pacific-throat-cancer-diagnostics-market
Middle East and Africa Throat Cancer Diagnostics Market https://www.databridgemarketresearch.com/reports/middle-east-and-africa-throat-cancer-diagnostics-market
North America Throat Cancer Diagnostics Market https://www.databridgemarketresearch.com/reports/north-america-throat-cancer-diagnostics-market
Global Hip Replacement Implants Market https://www.databridgemarketresearch.com/reports/global-hip-replacement-implants-market
Swiss Hip Replacement Implants Market https://www.databridgemarketresearch.com/reports/swiss-hip-replacement-implants-market
Global Polymerase Chain Reaction Market https://www.databridgemarketresearch.com/reports/global-polymerase-chain-reaction-market
U.S. Polymerase Chain Reaction Market https://www.databridgemarketresearch.com/reports/us-polymerase-chain-reaction-market
U.S. Bioabsorbable Orthopedics Implants Market https://www.databridgemarketresearch.com/reports/us-bioabsorbable-orthopedics-implants-market
U.A.E Aesthetics/Cosmetics Market https://www.databridgemarketresearch.com/reports/uae-aesthetics-cosmetics-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com